Advances and unmet needs in clinical studies on liver cirrhosis
10.3760/cma.j.issn.1007-3418.2019.12.001
- VernacularTitle: 肝硬化临床研究进展和未满足的需求
- Author:
Jinghang XU
1
;
Xiaoyuan XU
Author Information
1. Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China
- Publication Type:Editorial
- Keywords:
Liver cirrhosis;
Clinical study;
Advance;
Complication
- From:
Chinese Journal of Hepatology
2019;27(12):913-914
- CountryChina
- Language:Chinese
-
Abstract:
Liver cirrhosis is the end stage of a variety of chronic liver diseases. In recent years, a number of clinical studies related to cirrhosis have provided new evidence for natural history of cirrhosis, etiologic treatment and management of complications. The present article evaluates the cirrhosis-related articles in this issue and summarizes the advances of cirrhosis staging, antiviral therapy in patients with decompensated hepatitis C cirrhosis, drug treatment of portal hypertension, terlipressin in the treatment of cirrhotic ascites, and the management of portal vein thrombosis. The unmet needs in cirrhosis-related clinical studies are also discussed.
